[Elsevier] Unspecified degradation impurities identification and characterization in bilastine and montelukast tablet formulations by using UPLC and LCMS/MS: Robustness by design expert and green assessment |
|
This post will be closed automatically in 2026-07-19 18:54
Reward40points
|
10
CNTNAP1-encephalopathy: Six novel patients surviving the neonatal period
10
Strategies to promote pedestrian safety from the viewpoints of traffic and transport stakeholders in a developing country: A mixed-method study
10
Comparison of Raman and fluorescence microscopy for identification of small (< 2米m) microplastics in soil
30
Facilitating topic modeling in tourism research:Comprehensive comparison of new AI technologies
30
Why are you traveling? Inferring trip profiles from online reviews and domain-knowledge
